Literature DB >> 7613467

Engineering the substrate specificity of rhizopuspepsin: the role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in P1.

W T Lowther1, P Majer, B M Dunn.   

Abstract

Rhizopuspepsin and other fungal aspartic proteinases are distinct from the mammalian enzymes in that they are able to cleave substrates with lysine in the P1 position. Sequence and structural comparisons suggest that two aspartic acid residues, Asp 30 and Asp 77 (pig pepsin numbering), may be responsible for generating this unique specificity. Asp 30 and Asp 77 were changed to the corresponding residues in porcine pepsin, Ile 30 and Thr 77, to create single and double mutants. The zymogen forms of the wild-type and mutant enzymes were overexpressed in Escherichia coli as inclusion bodies. Following solubilization, denaturation, refolding, activation, and purification to homogeneity, structural and kinetic comparisons were made. The mutant enzymes exhibited a high degree of structural similarity to the wild-type recombinant protein and a native isozyme. The catalytic activities of the recombinant proteins were analyzed with chromogenic substrates containing lysine in the P1, P2, or P3 positions. Mutation of Asp 77 resulted in a loss of 7 kcal mol-1 of transition-state stabilization energy in the hydrolysis of the substrate containing lysine in P1. An inhibitor containing the positively charged P1-lysine side chain inhibited only the enzymes containing Asp 77. Inhibition of the Asp 77 mutants of rhizopuspepsin and several mammalian enzymes was restored upon acetylation of the lysine side chain. These results suggest that an exploitation of the specific electrostatic interaction of Asp 77 in the active site of fungal enzymes may lead to the design of compounds that preferentially inhibit a variety of related Candida proteinases in immunocompromised patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7613467      PMCID: PMC2143106          DOI: 10.1002/pro.5560040409

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  45 in total

1.  Primary structure of porcine pepsin. I. Purification and placement of cyanogen bromide fragments and the amino acid sequence of fragment CB5.

Authors:  K C Chen; N Tao; J Tang
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

2.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

3.  Determination and analysis of urea and guanidine hydrochloride denaturation curves.

Authors:  C N Pace
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

4.  Comparative specificity of microbial acid proteinases for synthetic peptides. 3. Relationship with their trypsinogen activating ability.

Authors:  K Morihara; T Oka
Journal:  Arch Biochem Biophys       Date:  1973-08       Impact factor: 4.013

5.  Rhizopus acid proteinases (rhizopus-pepsins): properties and homology with other acid proteinases.

Authors:  J E Graham; J Sodek; T Hofmann
Journal:  Can J Biochem       Date:  1973-06

Review 6.  On the rational design of renin inhibitors: X-ray studies of aspartic proteinases complexed with transition-state analogues.

Authors:  T L Blundell; J Cooper; S I Foundling; D M Jones; B Atrash; M Szelke
Journal:  Biochemistry       Date:  1987-09-08       Impact factor: 3.162

7.  Primary structure of human pepsinogen gene.

Authors:  K Sogawa; Y Fujii-Kuriyama; Y Mizukami; Y Ichihara; K Takahashi
Journal:  J Biol Chem       Date:  1983-04-25       Impact factor: 5.157

8.  Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action.

Authors:  K Suguna; E A Padlan; C W Smith; W D Carlson; D R Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

9.  Inhibition of aspartic proteinases by peptides containing lysine and ornithine side-chain analogues of statine.

Authors:  F G Salituro; N Agarwal; T Hofmann; D H Rich
Journal:  J Med Chem       Date:  1987-02       Impact factor: 7.446

10.  Electrostatic complementarity within the substrate-binding pocket of trypsin.

Authors:  L Gráf; A Jancsó; L Szilágyi; G Hegyi; K Pintér; G Náray-Szabó; J Hepp; K Medzihradszky; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  3 in total

1.  Active site specificity of plasmepsin II.

Authors:  J Westling; P Cipullo; S H Hung; H Saft; J B Dame; B M Dunn
Journal:  Protein Sci       Date:  1999-10       Impact factor: 6.725

2.  Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents.

Authors:  C Abad-Zapatero; R Goldman; S W Muchmore; C Hutchins; K Stewart; J Navaza; C D Payne; T L Ray
Journal:  Protein Sci       Date:  1996-04       Impact factor: 6.725

Review 3.  Molecular and biotechnological aspects of microbial proteases.

Authors:  M B Rao; A M Tanksale; M S Ghatge; V V Deshpande
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.